GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,286.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,120.05m
  • Volume: 3,828,082
  • Market Cap: £52,984m
  • RiskGrade: 129
  • Beta: 0.06

Latest ShareCast News

London close: Stocks fall as China retaliates to latest US tariffs

By Josh White

Date: Wednesday 09 Apr 2025

(Sharecast News) - London stocks fell sharply on Wednesday, with investors reacting to heightened geopolitical tensions after China unveiled retaliatory tariffs in response to a sweeping 104% import charge on Chinese goods announced by US president Donald Trump overnight.

GSK ShareCast News

London close: Stocks slide in global reaction to... 03-Apr-2025 ShareCast
UK pharma stocks avoid selloff 03-Apr-2025 ShareCast
EMA accepts GSK's application to expand Nucala use 24-Mar-2025 ShareCast
FDA to review GSK's depemokimab 03-Mar-2025 ShareCast
London close: Stocks little changed after UK dat... 21-Feb-2025 ShareCast

GSK Regulatory News

Transaction in Own Shares 11-Apr-2025 07:00 RNS
Transaction in Own Shares 10-Apr-2025 07:00 RNS
Transaction in Own Shares 09-Apr-2025 07:00 RNS
Transaction in Own Shares 08-Apr-2025 07:00 RNS
Transaction in Own Shares 07-Apr-2025 07:00 RNS

GSK Newspaper Links

AstraZeneca and GSK shares dive over fresh Trump... 09-Apr-2025 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,286.00p
Change Today 11.00p
% Change 0.86 %
52 Week High 1,812.50
52 Week Low 1,264.00
Volume 3,828,082
Shares Issued 4,120.05m
Market Cap £52,984m
Beta 0.06
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.38% below the market average26.38% below the market average26.38% below the market average26.38% below the market average26.38% below the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Price Trend
30.76% below the market average30.76% below the market average30.76% below the market average30.76% below the market average30.76% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Income
75.24% above the market average75.24% above the market average75.24% above the market average75.24% above the market average75.24% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
46.11% below the market average46.11% below the market average46.11% below the market average46.11% below the market average46.11% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 15
Sell 3
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 11-Apr-2025

Time Volume / Share Price
13:34 392 @ 1,286.00p
13:34 3 @ 1,286.50p
13:34 309 @ 1,286.30p
13:34 552 @ 1,286.00p
13:34 626 @ 1,286.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page